Artivion, Inc.AORTNYSE
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank43
3Y CAGR-1.6%
5Y CAGR+10.4%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

3Y CAGR
-1.6%/yr
vs -15.8%/yr prior
5Y CAGR
+10.4%/yr
Recent deceleration
Acceleration
+14.2pp
Accelerating
Percentile
P43
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
2 yr
Consecutive growthRecovering
PeriodValue
20258.92%
2024-0.89%
2023-26.16%
20229.38%
202146.84%
20205.43%
2019-0.60%
201818.69%
201744.73%
201628.84%